IGC Pharma, Inc. (IGC) stock
IGCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 2/3019% above fair value
$0.19+0.01 (+7.37%)
Close on Nov 17, 2026Market cap $19.43MP/E –Yield –
IGC Pharma market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
IGC Pharma's market cap was $20.37M on Nov 11, 2026, against $29.34M a year earlier. Over the last 5 years it ranged from $15.39M to $54.12M, with a median of $25.49M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $20.37M | -21.3% |
| 2025 | Dec 31, 2025 | $25.88M | +0.5% |
| 2024 | Dec 31, 2024 | $25.75M | +44.3% |
| 2023 | Dec 29, 2023 | $17.84M | +5.7% |
| 2022 | Dec 30, 2022 | $16.88M | -66.1% |
| 2021 | Dec 31, 2021 | $49.84M | -22.6% |
| 2020 | Dec 31, 2020 | $64.43M | +158.5% |
| 2019 | Dec 31, 2019 | $24.93M | +160.0% |
| 2018 | Dec 31, 2018 | $9.59M | +36264.7% |
| 2017 | Dec 29, 2017 | $26.37K | +317.4% |
| 2016 | Dec 30, 2016 | $6.32K | +72.3% |
| 2015 | Dec 31, 2015 | $3.67K | -52.6% |
| 2014 | Dec 31, 2014 | $7.73K | +5.5% |
| 2013 | Dec 31, 2013 | $7.33K | -7.5% |
| 2012 | Dec 31, 2012 | $7.92K | – |
See a number that looks wrong?